Cowen & Co. initiated coverage on IO Biotech
$IOBT
Biotechnology: Pharmaceutical Preparations
Health Care
Cowen & Co. initiated coverage of IO Biotech with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/30/2021 | $21.00 | Overweight | Morgan Stanley |
| 11/30/2021 | Outperform | Cowen & Co. | |
| 11/30/2021 | $20.00 | Buy | Jefferies |